Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Masson, S."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 64
Tytuł:
Sex differences in factors associated with heart failure and diastolic left ventricular dysfunction: a cross-sectional population-based study.
Autorzy:
Cesaroni G; Department of Epidemiology - Regional Health Service, ASL Roma 1, Via C. Colombo 112, 00147, Rome, Italy. .
Mureddu GF; Cardiology and Cardiovascular Rehabilitation Unit, S. Giovanni-Addolorata Hospital, Rome, Italy.
Agabiti N; Department of Epidemiology - Regional Health Service, ASL Roma 1, Via C. Colombo 112, 00147, Rome, Italy.
Mayer F; National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.
Stafoggia M; Department of Epidemiology - Regional Health Service, ASL Roma 1, Via C. Colombo 112, 00147, Rome, Italy.
Forastiere F; Department of Epidemiology - Regional Health Service, ASL Roma 1, Via C. Colombo 112, 00147, Rome, Italy.
Latini R; Mario Negri Institute for Pharmacological Research - IRCCS, Milan, Italy.
Masson S; Mario Negri Institute for Pharmacological Research - IRCCS, Milan, Italy.
Davoli M; Department of Epidemiology - Regional Health Service, ASL Roma 1, Via C. Colombo 112, 00147, Rome, Italy.
Boccanelli A; Quisisana Clinic, Rome, Italy.
Pokaż więcej
Corporate Authors:
PREDICTOR Study Group
Źródło:
BMC public health [BMC Public Health] 2021 Feb 27; Vol. 21 (1), pp. 415. Date of Electronic Publication: 2021 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Failure*/epidemiology
Ventricular Dysfunction, Left*/diagnostic imaging
Ventricular Dysfunction, Left*/epidemiology
Biomarkers ; Cross-Sectional Studies ; Female ; Humans ; Male ; Risk Factors ; Sex Characteristics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
Autorzy:
Cosmi F; Department of Cardiology, Ospedale di Cortona, Cortona, Italy.
Shen L; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Magnoli M; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Abraham WT; Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA.
Anand IS; Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, MN, USA.; Department of Cardiology, VA Medical Center, Minneapolis, MN, USA.
Cleland JG; Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Scotland, and Imperial College London, UK.
Cohn JN; Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, MN, USA.
Cosmi D; Department of Cardiology, Ospedale di Gubbio, Gubbio, Italy.
De Berardis G; CORESEARCH - Center for Outcomes Research and clinical Epidemiology, Pescara, Italy.
Dickstein K; Stavanger University Hospital, Stavanger, and the Institute of Internal Medicine, University of Bergen, Bergen, Norway.
Franzosi MG; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Gullestad L; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Kjekshus J; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Køber L; Department of Cardiology, Rigshospitalet, University Hospital, Copenhagen, Denmark.
Lepore V; CORESEARCH - Center for Outcomes Research and clinical Epidemiology, Pescara, Italy.
Lucisano G; CORESEARCH - Center for Outcomes Research and clinical Epidemiology, Pescara, Italy.
Maggioni AP; ANMCO Research Center, Florence, Italy.
Masson S; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Nicolucci A; CORESEARCH - Center for Outcomes Research and clinical Epidemiology, Pescara, Italy.
Petrarolo V; Regional Health Agency of Puglia, Bari, Italy.
Robusto F; CORESEARCH - Center for Outcomes Research and clinical Epidemiology, Pescara, Italy.
Staszewsky L; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Tavazzi L; GVM Hospitals of Care and Research, E.S. Health Science Foundation, Cotignola, Italy.
Teli R; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Tognoni G; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Wikstrand J; Sahlgrenska Academy, Gothenburg University, Sweden.
Latini R; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2018 May; Vol. 20 (5), pp. 888-895. Date of Electronic Publication: 2018 Feb 28.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Registries*
Diabetes Mellitus, Type 2/*drug therapy
Heart Failure/*epidemiology
Insulin/*therapeutic use
Aged ; Cause of Death/trends ; Comorbidity ; Diabetes Mellitus, Type 2/epidemiology ; Double-Blind Method ; Female ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Humans ; Hypoglycemic Agents/therapeutic use ; Italy/epidemiology ; Male ; Prognosis ; Propensity Score ; Risk Factors ; Survival Rate/trends
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HOME HF: an honest report of an (apparently) doable study.
Autorzy:
Masson S; Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Latini R; Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2018 Mar; Vol. 20 (3), pp. 481-482. Date of Electronic Publication: 2018 Jan 12.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Blood Pressure Monitoring, Ambulatory*
Heart Failure*
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
Autorzy:
Masson S; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Batkai S; Institute of Molecular and Translational Therapeutic Strategies and Excellence Cluster REBIRTH, Hannover Medical School, Hannover, Germany.
Beermann J; Institute of Molecular and Translational Therapeutic Strategies and Excellence Cluster REBIRTH, Hannover Medical School, Hannover, Germany.
Bär C; Institute of Molecular and Translational Therapeutic Strategies and Excellence Cluster REBIRTH, Hannover Medical School, Hannover, Germany.
Pfanne A; Institute of Molecular and Translational Therapeutic Strategies and Excellence Cluster REBIRTH, Hannover Medical School, Hannover, Germany.
Thum S; Institute of Molecular and Translational Therapeutic Strategies and Excellence Cluster REBIRTH, Hannover Medical School, Hannover, Germany.
Magnoli M; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Balconi G; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Nicolosi GL; Policlinico San Giorgio, Pordenone, Italy.
Tavazzi L; Maria Cecilia Hospital, GVM Care & Research - E.S. Health Science Foundation, Cotignola, (RA), Italy.
Latini R; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Thum T; Institute of Molecular and Translational Therapeutic Strategies and Excellence Cluster REBIRTH, Hannover Medical School, Hannover, Germany.; National Heart and Lung Institute, Imperial College London, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2018 Jan; Vol. 20 (1), pp. 78-85. Date of Electronic Publication: 2017 Oct 12.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Fatty Acids, Omega-3/*administration & dosage
Heart Failure/*blood
Hospitalization/*trends
MicroRNAs/*blood
Risk Assessment/*methods
Rosuvastatin Calcium/*administration & dosage
Stroke Volume/*physiology
Administration, Oral ; Aged ; Biomarkers/blood ; Circulating MicroRNA/blood ; Dose-Response Relationship, Drug ; Double-Blind Method ; Echocardiography ; Female ; Follow-Up Studies ; Germany/epidemiology ; Heart Failure/drug therapy ; Heart Failure/epidemiology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Italy/epidemiology ; Male ; MicroRNAs/genetics ; Morbidity/trends ; Prognosis ; Real-Time Polymerase Chain Reaction ; Risk Factors ; Stroke Volume/drug effects ; Survival Rate/trends
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.
Autorzy:
Ferreira JP; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Girerd N; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Pellicori P; Academic Cardiology Unit, University of Hull, Castle Hill Hospital, Kingston upon Hull, UK.
Duarte K; Université de Lorraine, Institut Elie Cartan de Lorraine, UMR 7502,, Vandoeuvre-lès-Nancy, F-54506, France.; CNRS, Institut Elie Cartan de Lorraine, UMR 7502,, Vandoeuvre-lès-Nancy, F-54506, France.; Team BIGS, INRIA, Villers-lès-Nancy, F-54600, France.
Girerd S; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Pfeffer MA; Division of Cardiovascular Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115, USA.
McMurray JJ; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MA, USA.; ASH Comprehensive Hypertension Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Chicago, Chicago, IL, USA.
Dickstein K; Department of Cardiology, University of Bergan, Stavanger University Hospital, Stavanger, Norway.
Jacobs L; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Staessen JA; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Butler J; Cardiology Division, Stony Brook University, Stony Brook, NY, USA.
Latini R; Laboratory of Cardiovascular Clinical Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Masson S; Laboratory of Cardiovascular Clinical Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Mebazaa A; Hôpital Lariboisière, Université Paris Diderot, Inserm 942, Paris, France.
Rocca HP; Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Delles C; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Heymans S; Department of Cardiology, Maastricht University Medical Center, Postbox 5800, 6202, AZ, Maastricht, The Netherlands.
Sattar N; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Jukema JW; Department of Cardiology and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands.
Cleland JG; National Heart and Lung Institute, Imperial College London (Royal Brompton and Harefield Hospitals) Department of Cardiology, Castle Hill Hospital, University of Hull, Hull, UK.
Zannad F; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Rossignol P; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France. .; Centre d'Investigations Cliniques-INSERM CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, 4 Rue du Morvan, 54500, Vandoeuvre lès Nancy, France. .
Pokaż więcej
Corporate Authors:
Heart ‘OMics’ in AGEing (HOMAGE) initiative and the High-Risk Myocardial Infarction database initiative
Źródło:
BMC medicine [BMC Med] 2016 Nov 10; Vol. 14 (1), pp. 181. Date of Electronic Publication: 2016 Nov 10.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Population Surveillance*/methods
Aging/*physiology
Heart Failure/*mortality
Kidney/*physiology
Myocardial Infarction/*mortality
Renal Insufficiency, Chronic/*mortality
Adult ; Aged ; Aged, 80 and over ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/physiopathology ; Cohort Studies ; Databases, Factual/trends ; Female ; Glomerular Filtration Rate/physiology ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Myocardial Infarction/diagnosis ; Myocardial Infarction/physiopathology ; Predictive Value of Tests ; Renal Insufficiency, Chronic/diagnosis ; Renal Insufficiency, Chronic/physiopathology ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Understanding and making good use of changes in natriuretic peptide levels in chronic heart failure.
Autorzy:
Latini R; Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Masson S; Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2015 Aug; Vol. 17 (8), pp. 758-9. Date of Electronic Publication: 2015 Jul 15.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Biomarkers/*blood
Heart Failure/*physiopathology
Natriuretic Peptide, Brain/*blood
Peptide Fragments/*blood
Female ; Humans ; Male
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials.
Autorzy:
Rossignol P; INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, Nancy, France; Université de Lorraine, France; INSERM U1116, Nancy, France.
Masson S
Barlera S
Girerd N
Castelnovo A
Zannad F
Clemenza F
Tognoni G
Anand IS
Cohn JN
Anker SD
Tavazzi L
Latini R
Pokaż więcej
Corporate Authors:
GISSI-HF and Val-HeFT Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2015 Apr; Vol. 17 (4), pp. 424-33. Date of Electronic Publication: 2015 Feb 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure/*mortality
Plasma Volume/*physiology
Weight Loss/*physiology
Adult ; Aged ; Aged, 80 and over ; Biomarkers/blood ; C-Reactive Protein/metabolism ; Cachexia/metabolism ; Clinical Trials as Topic ; Female ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Prognosis ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial.
Autorzy:
Aleksova A; Cardiovascular Department, 'Ospedali Riuniti' and University of Trieste, Trieste, Italy.
Masson S
Maggioni AP
Lucci D
Fabbri G
Beretta L
Mos L
Paino AM
Nicolosi GL
Marchioli R
Tognoni G
Tavazzi L
Sinagra G
Latini R
Pokaż więcej
Corporate Authors:
GISSI-Heart Failure Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2013 Nov; Vol. 15 (11), pp. 1289-95. Date of Electronic Publication: 2013 Jul 09.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation/*prevention & control
Fatty Acids, Omega-3/*therapeutic use
Heart Failure/*drug therapy
Aged ; Atrial Fibrillation/blood ; Atrial Fibrillation/complications ; Chronic Disease ; Double-Blind Method ; Fatty Acids, Omega-3/blood ; Female ; Heart Failure/blood ; Heart Failure/complications ; Humans ; Logistic Models ; Male ; Middle Aged ; Proportional Hazards Models ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from 'PREDICTOR', a population based-study in central Italy.
Autorzy:
Mureddu GF; Department of Cardiovascular Diseases, S. Giovanni-Addolorata Hospital, Via Amba Aradam 9, 00184, Roma, Italy.
Tarantini L
Agabiti N
Faggiano P
Masson S
Latini R
Cesaroni G
Miceli M
Forastiere F
Scardovi AB
Uguccioni M
Boccanelli A
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2013 Oct; Vol. 15 (10), pp. 1102-12. Date of Electronic Publication: 2013 Jun 20.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Failure/*diagnosis
Ventricular Dysfunction, Left/*diagnosis
Aged ; Aged, 80 and over ; Asymptomatic Diseases ; Cost-Benefit Analysis ; Diastole ; Echocardiography, Doppler/economics ; Echocardiography, Doppler/methods ; Electrocardiography/economics ; Electrocardiography/methods ; Female ; Heart Failure/blood ; Heart Failure/diagnostic imaging ; Humans ; Italy ; Male ; Mass Screening/economics ; Mass Screening/methods ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Predictive Value of Tests ; Risk Factors ; Sensitivity and Specificity ; Stroke Volume ; Systole ; Ventricular Dysfunction, Left/blood ; Ventricular Dysfunction, Left/diagnostic imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.
Autorzy:
Ueland T; Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway. />Nymo SH
Latini R
McMurray JJ
Kjekshus J
Yndestad A
Fucili A
Grosu A
Masson S
Maggioni AP
Gullestad L
Aukrust P
Pokaż więcej
Corporate Authors:
Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) trial
Investigators of the GISSI-Heart Failure (GISSI-HF) trial
Źródło:
European journal of heart failure [Eur J Heart Fail] 2013 Jul; Vol. 15 (7), pp. 747-55. Date of Electronic Publication: 2013 Mar 13.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemokine CCL21/*blood
Fluorobenzenes/*therapeutic use
Heart Failure/*blood
Pyrimidines/*therapeutic use
Sulfonamides/*therapeutic use
Aged ; Disease Progression ; Double-Blind Method ; Female ; Heart Failure/drug therapy ; Heart Failure/mortality ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Kaplan-Meier Estimate ; Male ; Norway/epidemiology ; Prognosis ; Proportional Hazards Models ; Risk Factors ; Rosuvastatin Calcium ; Survival Rate/trends ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adiponectin in chronic heart failure: influence of diabetes and genetic variants.
Autorzy:
Masson S; Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy. serge.masson@marionegri.it
Gori F
Latini R
Milani V
Flyvbjerg A
Frystyk J
Crociati L
Pietri S
Vago T
Barlera S
Maggioni AP
Tognoni G
Tavazzi L
Omland T
Franzosi MG
Pokaż więcej
Corporate Authors:
GISSI-HF Investigators
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2011 Dec; Vol. 41 (12), pp. 1330-8. Date of Electronic Publication: 2011 May 30.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Adiponectin/*genetics
Diabetes Mellitus, Type 2/*genetics
Heart Failure/*genetics
Adiponectin/metabolism ; Age Factors ; Aged ; Aged, 80 and over ; Body Mass Index ; Diabetes Mellitus, Type 2/complications ; Female ; Genetic Predisposition to Disease/genetics ; Heart Failure/blood ; Heart Failure/complications ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Risk Factors ; Sex Factors ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial.
Autorzy:
Røsjø H; Division of Medicine, Akershus University Hospital, Lørenskog, Norway.
Masson S
Latini R
Flyvbjerg A
Milani V
La Rovere MT
Revera M
Mezzani A
Tognoni G
Tavazzi L
Omland T
Pokaż więcej
Corporate Authors:
GISSI-HF Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2010 Jun; Vol. 12 (6), pp. 549-56. Date of Electronic Publication: 2010 Apr 13.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromogranin A/*blood
Heart Failure/*blood
Aged ; Aged, 80 and over ; Biomarkers/blood ; Chronic Disease ; Female ; Humans ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.
Autorzy:
Masson S; Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, via La Masa 19, Milan, Italy. serge.masson@marionegri.it
Latini R
Carbonieri E
Moretti L
Rossi MG
Ciricugno S
Milani V
Marchioli R
Struck J
Bergmann A
Maggioni AP
Tognoni G
Tavazzi L
Pokaż więcej
Corporate Authors:
GISSI-HF Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2010 Apr; Vol. 12 (4), pp. 338-47. Date of Electronic Publication: 2010 Jan 22.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Peptide Fragments*
Heart Failure/*diagnosis
Adrenomedullin ; Aged ; Atrial Natriuretic Factor ; Biomarkers ; Confidence Intervals ; Double-Blind Method ; Female ; Heart Failure/physiopathology ; Humans ; Italy ; Kaplan-Meier Estimate ; Linear Models ; Male ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; ROC Curve ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results.
Autorzy:
Boccanelli A; Department of Cardiovascular Diseases, San Giovanni-Addolorata Hospital, Roma, Italy.
Mureddu GF
Cacciatore G
Clemenza F
Di Lenarda A
Gavazzi A
Porcu M
Latini R
Lucci D
Maggioni AP
Masson S
Vanasia M
de Simone G
Pokaż więcej
Corporate Authors:
AREA IN-CHF Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2009 Jan; Vol. 11 (1), pp. 68-76.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Canrenone/*pharmacology
Heart Failure/*physiopathology
Mineralocorticoid Receptor Antagonists/*pharmacology
Ventricular Remodeling/*drug effects
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Chronic Disease ; Creatinine/blood ; Double-Blind Method ; Female ; Heart Failure/classification ; Heart Failure/diagnostic imaging ; Humans ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Treatment Outcome ; Ultrasonography ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 64

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies